SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
cas2197-sup-0001-figureS1.tifimage/tif233KFig. S1. T-LAK cell-originated protein kinase/PDZ-binding kinase (TOPK/PBK) is overexpressed in lung cancer from microarray studies.
cas2197-sup-0002-figureS2.tifimage/tif144KFig. S2. Relapse-free survival based on T-LAK cell-originated protein kinase (TOPK) immunohistochemistry (IHC) score.
cas2197-sup-0003-figureS3.tifimage/tif119KFig. S3. Time to recurrence analysis of 21 cases of stage I lung carcinoma from Kaohsing Medical University Hospital based on T-LAK cell-originated protein kinase (TOPK) immunohistochemistry (IHC) score.
cas2197-sup-0004-figureS4.tifimage/tif89KFig. S4. Overall patient survival rate based on epidermal growth factor receptor (EGFR) mutation status.
cas2197-sup-0005-figureS5.tifimage/tif89KFig. S5. Time to recurrence based on epidermal growth factor receptor (EGFR) mutation status.
cas2197-sup-0006-TableS1.pdfPDF document20KTable S1. Epidermal growth factor receptor (EGFR) mutation status of 67 lung adenocarcinoma samples.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.